Psoriasis Drugs Could Cause Suicide Risk
Valeant Pharmaceuticals International Inc’s experimental drug to treat the skin disorder psoriasis carries a potential risk of suicide. However, the risk is challenging to assess due to limited data, according to a preliminary review by the US Food and Drug Administration (FDA), recently published. Reported on www.reuters.com, in clinical trials of the drug, brodalumab, there [...]